Biomarkers in critical illness: have we made progress?

Biomarkers have emerged as exemplary key players in translational medicine. Many have been assessed for timely recognition, early treatment, and adequate follow-up for a variety of pathologies. Biomarker sensitivity has improved considerably over the last years but specificity remains poor, in parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Honore, Patrick M, Jacobs, Rita, Hendrickx, Inne, De Waele, Elisabeth, Van Gorp, Viola, Joannes-Boyau, Olivier, De Regt, Jouke, Boer, Willem, Spapen, Herbert D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074734/
https://www.ncbi.nlm.nih.gov/pubmed/27799811
http://dx.doi.org/10.2147/IJNRD.S113219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074734/
https://www.ncbi.nlm.nih.gov/pubmed/27799811
http://dx.doi.org/10.2147/IJNRD.S113219

Ejemplares similares